In the BioHarmony Drug Report Database
Bromodiphenhydramine
Ambodryl (bromodiphenhydramine) is a small molecule pharmaceutical. Bromodiphenhydramine was first approved as Ambodryl on 1982-01-01. It is used to treat allergic rhinitis perennial, anxiety disorders, cough, motion sickness, and nausea amongst others in the USA.
Trade Name
|
Ambodryl |
---|---|
Common Name
|
bromodiphenhydramine |
ChEMBL ID
|
CHEMBL1201245 |
Indication
|
allergic rhinitis perennial, anxiety disorders, cough, motion sickness, nausea, parkinson disease, sleep initiation and maintenance disorders, urticaria, vertigo, vomiting |
Drug Class
|
Image (chem structure or protein)